Process for topically producing cutaneous vasodilation for the t

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424311, 424317, 424331, A61K 31215

Patent

active

043117074

ABSTRACT:
This application discloses a process for producing cutaneous vasodilation which comprises the topical administration to an individual with a vasospastic or ischemic condition of an effective dosage of a prostaglandin vasodilator of the natural or synthetic prostaglandin analogs of the PGE, PGA, or PGF.sub..beta. types.

REFERENCES:
patent: 3551554 (1970-12-01), Herschler
patent: 4131738 (1978-12-01), Smith
patent: 4158667 (1979-06-01), Axen
Lowe and Stoughton--J. of Investigative Dermatology, 68:134-137, 1977.
Merck Manual--10th Ed., 1961, pp. 238, 239, 1426-1429.
Conway et al.--Chem. Abst., vol. 83 (1975), p. 91,369e.
Harrison et al.--Chem. Abst., vol. 83 (1975), p. 53,742p.
Williams et al.--Chem. Abst., vol. 88 (1978), p. 183,486x

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Process for topically producing cutaneous vasodilation for the t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for topically producing cutaneous vasodilation for the t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for topically producing cutaneous vasodilation for the t will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1915171

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.